Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...
Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
And although it's a signal that branded versions of tirzepatide-based drugs – Mounjaro, for diabetes, and Zepbound, ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...